Nobivac Feline 1-HCPCH+FeLV

Description

NOBIVAC® Feline 1-HCPCh+ FeLV has been shown to be effective for vaccination of healthy cats 9 weeks of age or older against feline rhinotracheitis, calici, panleukopenia, and feline leukemia viruses, as well as feline Chlamydophila. The duration of immunity against feline leukemia virus is at least 2 years. Also shown to be effective against persistent viremia in cats exposed to virulent feline leukemia virus. (Previously knowns as Chlamydia psittaci)
Proven safety profile-99% reaction-free in ongoing surveillance involving millions of doses.1
Subcutaneous or intramuscular injection
Initial 1 mL dose administered at 9 weeks of age or older
Second 1 mL dose administered 3 to 4 weeks later
Historically, annual revaccination has been recommended for this product. The need for this booster has not been established. For more information on revaccination frequency, in general or in the face of maternal antibody, consult your veterinarian or the manufacturer.Available in a 25 x 1 mL dose presentation

 

Dosage and Administration

Two doses are required for primary immunization.

• Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.
• Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.

Revaccinate every two years with a single dose of Nobivac^® Feline 1-HCPCh+FeLV. 

WARNINGS:

• Contains gentamicin and amphotericin B as preservatives.
• Some reports suggest that in cats, the administration of certain veterinary biologicals may induce the development of injection-site fibrosarcomas.
• Do not vaccinate pregnant cats.
• The use of a biological product may produce anaphylaxis and/or other inflammatory immune-mediated hypersensitivity reactions. Antidote: Epinephrine, corticosteroids, and antihistamines may all be indicated depending on the nature and severity of the reaction.
• It is important to realize that certain conditions and events may cause some cats to be unable to develop or maintain an adequate immune response following FeLV vaccination. Prior exposure to the disease, or disease latency, are conditions in which vaccination may not alter the course of the disease. Therefore, diagnostic testing of all cats for FeLV antigen prior to vaccination is recommended. Also, vaccination with this product will not offer cross-protection against feline immunodeficiency virus (FIV), another feline retrovirus. It is important to advise the cat owner of these situations prior to vaccination.

Nobivac Feline 1-HCOCH+FeLV is a registered trademark of Intervet Inc., d/b/a Merck Animal Health, a subsidiary of Merck & Co. Inc.

---

All Vaccines Now Ship OVERNIGHT Delivery Only at a great LOW Rate!
Vaccines are shipped in a cooling package on Monday-Thursdays. 
Click here for our Vaccine Shipping Schedule.

Nobivac^® Feline 1-HCPCh + FeLV vaccine is a combination vaccine that unites the benefits of Nobivac^® Feline 1-HCPCh and Nobivac^® FeLV in one vaccination.

Nobivac^® Feline 1-HCPCh vaccine is a modified live virus and chlamydia vaccine for the vaccination of healthy cats as an aid in the prevention of disease caused by feline rhinotracheitis, calici, and panleukopenia viruses and Chlamydia psittaci.

Nobivac^® FeLV vaccine is recommended for the vaccination of healthy cats as an aid in the prevention of lymphoid tumors caused by, and diseases associated with, feline leukemia virus (FeLV) infection. Vaccination with this product prevents persistent viremia in cats exposed to virulent feline leukemia virus.

The feline leukemia virus, subgroups A and B, are cultured in tissue culture cells. The virus has been chemically inactivated and combined with a proprietary adjuvant designed to enhance the immune response.

DOSAGE AND ADMINISTRATION:

Prior to use, warm the Nobivac® FeLV to room temperature and shake well.

Transfer contents of the Nobivac^® FeLV vial to the Nobivac^® Feline 1-HCPCh vial aseptically. Mix gently until dissolved. Use entire contents immediately after rehydration.

Two doses are required for primary immunization.

Initial vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly at 9 weeks of age or older.

Second vaccination: Inject 1 dose (1 mL) subcutaneously or intramuscularly 3 to 4 weeks following the initial vaccination.

Revaccinate every two years with a single dose of Nobivac^® Feline 1-HCPCh+FeLV. Revaccination in the intervening years with Nobivac^® Feline 1-HCPCh is recommended. Following the advice of the American Veterinary Medical Association on Vaccination Principles, an appropriate revaccination program for individual animals should be made based upon veterinarian-client-patient relationships.

Do not vaccinate pregnant cats.

---

All Vaccines Now Ship OVERNIGHT Delivery Only at a great LOW Rate!
Vaccines are shipped in a cooling package on Monday-Thursdays (on orders placed before 2:00p.m.) 

Click here for our Vaccine Shipping Schedule.